Meetings: National Institute of Allergy and Infectious Diseases,

[Federal Register: March 17, 2008 (Volume 73, Number 52)]

[Notices]

[Page 14258-14259]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr17mr08-71]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel Pathogenesis of Francisella Tularensis.

Date: April 9, 2008.

Time: 1 p.m. to 4 p.m.

Agenda: To review and evaluate grant applications.

[[Page 14259]]

Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call).

Contact Person: Eugene R. Baizman, PhD, Scientific Review Officer, DHHS/NIAID/DEA/SRP, Room 3125, 6700B Rockledge Drive, Bethesda, MD 20892-7616, 301-402-1464, ebaizman@niaid.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: March 7, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy.

[FR Doc. E8-5082 Filed 3-14-08; 8:45 am]

BILLING CODE 4140-01-M

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT